Drugs / SCTV01E
last change Nov 2024 re-read 2 minutes ago

SCTV01E

Vaccine

Developed for
COVID-19
Investigated by
Sinocelltech Ltd.

Trials 9 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 26 trials
Phase 2 NCT05652543 Jan 2023 → Jan 2024 COVID-19 Sinocelltech Ltd. Completed No outcome recorded
Phase 2 NCT05345873 Jul → Oct 2022 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 2 NCT05329051 Jul → Sep 2022 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 2 NCT05239806 Apr → Aug 2022 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 2 NCT05308602 Apr → Aug 2022 COVID-19 Sinocelltech Ltd. Withdrawn No outcome recorded
Phase 2 NCT05238441 Mar → Jun 2022 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 33 trials
Phase 3 NCT05683561 Jan → Aug 2023 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 3 NCT05308576 Dec 2022 → May 2023 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 3 NCT05323461 May → Oct 2022 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05933512 Comparator Aug → Dec 2023 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded
Phase 2 NCT05522829 Comparator Oct → Dec 2022 COVID-19 Sinocelltech Ltd. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as SCTV01E ClinicalTrials.gov intervention name — accepted as the source's own label NCT05933512
10

NCT05683561

NCT05308602

NCT05308576

NCT05238441

NCT05323461

NCT05522829

NCT05345873

NCT05329051

NCT05652543

NCT05239806

Modality Vaccine “SCTV01E (A COVID-19 Alpha/Beta/Delta/Omicron Variants S-Trimer Vaccine)” NCT05238441
Route Intramuscular “D0; intramuscular injection” NCT05238441